ALX Oncology Holdings Inc. is a fully public corporate entity listed on the NASDAQ Global Select Market under the official ticker symbol ALXO. This public market status enables institutional investment funds, healthcare venture funds, and retail shareholders to trade its common stock under regular regulatory disclosure frameworks governed by the SEC.